Healius Company Description
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia.
The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services.
The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands.
It operates medical laboratories, medical centers, patient collection centers, and community imaging centers.
The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018.
Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Country | Australia |
Founded | 1994 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 9,658 |
CEO | Paul Anderson |
Contact Details
Address: 161 Castlereagh Street Sydney, Victoria 2000 Australia | |
Phone | 61 2 9432 9400 |
Website | healius.com.au |
Stock Details
Ticker Symbol | HLS |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU0000033359 |
SIC Code | 8011 |
Key Executives
Name | Position |
---|---|
Paul D. Anderson B.Com., C.A. | MD, Chief Executive Officer and Director |
Stephen Humphries B.Sc. | Chief Financial Officer& Company Secretary |
Dr. Jan Van Rooyen | Head and Group Executive of Healius Pathology |
Paula Bayliss | Group Executive of People and Culture |
John McKechnie | Advisor |
Dr. Phil Lucas | Chief Executive of Lumus Imaging |
Ian Mcphan | Chief Operating Officer of Healius Pathology |
Sharon Ng | Head of Group FP&A |
Arjun Narang | Group Executive of Operations Transformation |
Jon Eide | Group Executive of Commercial and Customer |